(Q37781786)

23 August 2017

title

A review on the current state of urine cytology emphasizing the role of fluorescence in situ hybridization as an adjunct to diagnosis (English)

1 reference

fluorescence in situ hybridization

23 August 2017

0 references

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20731004

21 June 2024

author name string

Nancy P. Caraway

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20731004

21 June 2024

Ruth L. Katz

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20731004

21 June 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20731004

21 June 2024

publication date

1 August 2010

1 reference

23 August 2017

25 August 2010

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20731004

full work available at URL

21 June 2024

https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cncy.20080

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20731004

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fcncy.20080

21 June 2024

1 reference

https://onlinelibrary.wiley.com/doi/full/10.1002/cncy.20080

21 June 2024

1 reference

21 June 2024

1 reference

23 August 2017

volume

118

1 reference

23 August 2017

issue

4

1 reference

23 August 2017

page(s)

175-183

1 reference

Development of a novel proteomic approach for the detection of transitional cell carcinoma of the bladder in urine

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20080

21 January 2018

Cancer statistics, 2009

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20080

7 January 2021

Natural history and treatment of low and high risk superficial bladder tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20080

7 January 2021

Superficial bladder cancer: progression and recurrence

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20080

7 January 2021

Bladder cancer detection using FISH (UroVysion assay).

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20080

7 January 2021

Can urine bound diagnostic tests replace cystoscopy in the management of bladder cancer?

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20080

7 January 2021

Use of a multitarget fluorescence in situ hybridization assay to diagnose bladder cancer in patients with hematuria

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20080

7 January 2021

UroVysion compared with cytology and quantitative cytology in the surveillance of non-muscle-invasive bladder cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20080

7 January 2021

Comparison of the ImmunoCyt test and urinary cytology with other urine tests in the detection and surveillance of bladder cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20080

7 January 2021

ImmunoCyt/uCyt+ improves the sensitivity of urine cytology in patients followed for urothelial carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20080

7 January 2021

Clinical decisions for treatment of different staged bladder cancer based on multitarget fluorescence in situ hybridization assays?

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20080

7 January 2021

Fluorescence in situ hybridization for detecting transitional cell carcinoma: implications for clinical practice

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20080

7 January 2021

uCyt+ test: alternative to cystoscopy for less-invasive follow-up of patients with low risk of urothelial carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20080

7 January 2021

Multiprobe fluorescence in situ hybridisation: prognostic perspectives in superficial bladder cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20080

7 January 2021

A side by side comparison of cytology and biomarkers for bladder cancer detection.

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20080

7 January 2021

A comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20080

7 January 2021

Low-grade urothelial carcinoma: reappraisal of the cytologic criteria on ThinPrep

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20080

7 January 2021

Diagnostic problems of urine cytology on initial follow-up after intravesical immunotherapy with Calmette-Guérin bacillus for superficial bladder cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20080

7 January 2021

Urinary cytology and bladder cancer. The cellular features of transitional cell neoplasms

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20080

7 January 2021

Reliability of the routine cytological diagnosis in bladder cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20080

7 January 2021

Differences between local and review urinary cytology in diagnosis of bladder cancer. An interobserver multicenter analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20080

7 January 2021

The accuracy of urinary cytology in daily practice

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20080

7 January 2021

The new World Health Organization/International Society of Urological Pathology (WHO/ISUP) classification for TA, T1 bladder tumors: is it an improvement?

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20080

7 January 2021

Non-invasive papillary urothelial neoplasms: the 2004 WHO/ISUP classification system

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20080

7 January 2021

Cytologic diagnosis of low-grade papillary urothelial neoplasms (low malignant potential and low-grade carcinoma) in the context of the 1998 WHO/ISUP classification

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20080

7 January 2021

Molecular pathogenesis and diagnostics of bladder cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20080

7 January 2021

Biomarkers for detection and surveillance of bladder cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20080

7 January 2021

Bladder cancer biomarkers and their role in surveillance and screening

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20080

7 January 2021

A study comparing various noninvasive methods of detecting bladder cancer in urine

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20080

7 January 2021

Exclusion criteria enhance the specificity and positive predictive value of NMP22 and BTA stat

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20080

7 January 2021

Evaluation of nuclear matrix protein-22 as a clinical diagnostic marker for bladder cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20080

7 January 2021

Performance of urine test in patients monitored for recurrence of bladder cancer: a multicenter study in the United States

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20080

7 January 2021

Sensitivity and specificity of NMP-22, telomerase, and BTA in the detection of human bladder cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20080

7 January 2021

NMP22 is a sensitive, cost-effective test in patients at risk for bladder cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20080

7 January 2021

Surveillance for recurrent bladder cancer using a point-of-care proteomic assay

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20080

7 January 2021

Multitarget fluorescence in situ hybridization assay detects transitional cell carcinoma in the majority of patients with bladder cancer and atypical or negative urine cytology

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20080

7 January 2021

Clinical evaluation of a multi-target fluorescent in situ hybridization assay for detection of bladder cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20080

7 January 2021

Fluorescence in situ hybridization: a multitarget approach in diagnosis and management of urothelial cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20080

7 January 2021

Urothelial cancer biomarkers for detection and surveillance

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20080

7 January 2021

Effect of intravesical instillations on the human complement factor H related protein (BTA stat) test

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20080

7 January 2021

Multi-target fluorescence in situ hybridization in bladder washings for prediction of recurrent bladder cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20080

7 January 2021

Fluorescence in situ hybridization in diagnostic cytology

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20080

7 January 2021

Comparative diagnostic value of urine cytology, UBC-ELISA, and fluorescence in situ hybridization for detection of transitional cell carcinoma of urinary bladder in routine clinical practice

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20080

7 January 2021

Reflex UroVysion testing in suspicious urine cytology cases

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20080

7 January 2021

The prognostic value of cytology and fluorescence in situ hybridization in the follow-up of nonmuscle-invasive bladder cancer after intravesical Bacillus Calmette-Guérin therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20080

7 January 2021

Monitoring intravesical therapy for superficial bladder cancer using fluorescence in situ hybridization.

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20080

7 January 2021

DNA image cytometry and fluorescence in situ hybridization for noninvasive detection of urothelial tumors in voided urine

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20080

7 January 2021

Detection of bladder cancer from the urine using fluorescence in situ hybridization technique.

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20080

7 January 2021

Reflex UroVysion testing of bladder cancer surveillance patients with equivocal or negative urine cytology: a prospective study with focus on the natural history of anticipatory positive findings

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20080

7 January 2021

Should we abandon the FISH test?

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20080

7 January 2021

"FISHing" to detect urinary and other cancers: validation of an imaging system to aid in interpretation

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20080

7 January 2021

Combined analysis of morphology and fluorescence in situ hybridization significantly increases accuracy of bladder cancer detection in voided urine samples

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20080

7 January 2021

New developments in automated cytogenetic imaging: unattended scoring of dicentric chromosomes, micronuclei, single cell gel electrophoresis, and fluorescence signals.

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20080

7 January 2021

A public-domain image processing tool for automated quantification of fluorescence in situ hybridisation signals

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20080

7 January 2021

Economic impact of tumor markers in bladder cancer surveillance

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20080

7 January 2021

The health economics of bladder cancer: a comprehensive review of the published literature.

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20080

7 January 2021

Follow-up in non-muscle invasive bladder cancer: facts and future

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20080

7 January 2021

Molecular markers of urothelial cancer and their use in the monitoring of superficial urothelial cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20080

7 January 2021

Quantitation of Aurora kinase A gene copy number in urine sediments and bladder cancer detection

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20080

7 January 2021

Relevance of Urine Telomerase in the Diagnosis of Bladder Cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20080

7 January 2021

Assessment of microsatellite instability in urine in the detection of transitional-cell carcinoma of the bladder

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20080

7 January 2021

The promising future of proteomics in cancer diagnosis and treatment

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20080

7 January 2021

Molecular detection of primary bladder cancer by microsatellite analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20080

7 January 2021

Genetic instability and transitional cell carcinoma of the bladder

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20080

7 January 2021

Microsatellite alterations in human bladder cancer: detection of tumor cells in urine sediment and tumor tissue

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.20080

7 January 2021

Prognostic accuracy of individual uropathologists in noninvasive urinary bladder carcinoma: a multicentre study comparing the 1973 and 2004 World Health Organisation classifications

27

1 reference

Surveillance of patients with bladder carcinoma using fluorescent in-situ hybridization on bladder washings.

21 June 2024

57

1 reference

Economic evaluation of NMP22 in the management of bladder cancer

21 June 2024

71

1 reference

21 June 2024

Identifiers

DOI

10.1002/CNCY.20080

1 reference

23 August 2017

1 reference